Literatures have shown that mTOR is a critical signaling pathway involved in the pathophysiology of breast cancer and flavonoids due to its interfering potential with these mTOR cascades have shown them targeting candidates for breast cancer therapy [25–27]. The gene discussed is MTOR; the disease is breast carcinoma.